Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
XLV vs XOP: how they differ
XLV and XOP hold 0% of their weight in the same names, and XOP returned more over the year.
State Street(R) Health Care Select Sector SPDR(R) ETF and State Street(R) SPDR(R) S&P(R) Oil & Gas Exploration & Production ETF.
What they hold in common
By the books each fund has filed, XLV and XOP hold 0% of their money in the same securities at the same weight.
| Only in XLV | Only in XOP |
|---|---|
| Eli Lilly & Co 16.56% | Texas Pacific Land Corp 3.17% |
| Johnson & Johnson 10.67% | PBF Energy Inc 2.91% |
| AbbVie Inc 7.76% | Delek US Holdings Inc 2.81% |
| UnitedHealth Group Inc 6.59% | Expand Energy Corp 2.80% |
| Merck & Co Inc 5.54% | CNX Resources Corp 2.78% |
| Amgen Inc 3.41% | EQT Corp 2.75% |
| Thermo Fisher Scientific Inc 3.25% | Valero Energy Corp 2.75% |
| Abbott Laboratories 2.76% | Antero Resources Corp 2.68% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| XLV State Street(R) Health Care Select Sector SPDR(R) ETF | XOP State Street(R) SPDR(R) S&P(R) Oil & Gas Exploration & Production ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | State Street | State Street |
| What it is | Health care | SPDR S&P Oil & Gas Exploration & Production |
| Total return, 1 year | +20.4% | +52.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +2.9 pts | +34.9 pts |
| Expense ratio | 0.08% | 0.35% |
| Holdings | 59 | 51 |
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
XOP in plain words
XOP is a commodity fund tracking the SPDR S&P Oil & Gas Exploration & Production. Over the year to Sep 11, 2026 it returned +52.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. It sat 26.8% below its high of Jun 23, 2014 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, XLV or XOP?
- In the year to Sep 12, 2026, with distributions reinvested, XLV returned +20.4% and XOP returned +52.4%, so XOP returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, XLV or XOP?
- XLV charges 0.08% a year and XOP charges 0.35%, so XLV is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, XLV against XOP, data as of Sep 12, 2026. https://etfiq.com/compare/any/XLV-XOP Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources